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PCardiac Imaging
ssessment of Non–ST-Segment
levation Acute Coronary Syndromes
ith Cardiac Magnetic Resonance Imaging
ven Plein, MD,* John P. Greenwood, PHD,* John P. Ridgway, PHD,† Gillian Cranny, MSC,‡
tephen G. Ball, PHD,§ Mohan U. Sivananthan, MD*
eeds, United Kingdom
OBJECTIVES The goal of this study was to determine: 1) if the presence of significant coronary stenosis in
patients presenting with non–ST-segment elevation acute coronary syndromes (NSTE-ACS)
can be predicted by cardiac magnetic resonance (CMR) imaging; and 2) if the analysis of
several CMR methods improves its diagnostic yield compared with analysis of individual
methods.
BACKGROUND With modern acquisition techniques, several CMR methods for the assessment of coronary
artery disease (CAD) can be combined in a single noninvasive scanning session. Such a
multicomponent CMR examination has not previously been applied to a large patient
population, in particular those with a high prevalence of CAD in an acute situation.
METHODS Sixty-eight patients presenting with NSTE-ACS underwent CMR imaging of myocardial
function, perfusion (rest and adenosine-stress), viability (by late contrast enhancement), and
coronary artery anatomy. Visual analysis of CMR was carried out. First, all CMR data were
reviewed in combination (“comprehensive analysis”). In further separate analyses, each CMR
method was analyzed individually. The ability of CMR to detect coronary stenosis 70% on
X-ray angiography was determined.
RESULTS Comprehensive CMR analysis yielded a sensitivity of 96% and a specificity of 83% to predict
the presence of significant coronary stenosis and was more accurate than analysis of any
individual CMR method; CMR was significantly more sensitive and accurate than the
Thrombolysis In Myocardial Infarction risk score (p  0.001).
CONCLUSIONS Cardiac magnetic resonance imaging accurately predicts the presence of significant CAD in
patients with NSTE-ACS. In this study, a comprehensive analysis of several CMR methods
improved the accuracy of the test. (J Am Coll Cardiol 2004;44:2173–81) © 2004 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.056American College of Cardiology Foundation
m
u
n
m
o
a
s
O
p
c
n
a
u
s
I
t
t
N
c
aardiac magnetic resonance (CMR) imaging can provide a
ide range of information that is relevant to the clinical
anagement of patients with known or suspected coronary
rtery disease (CAD). Among others, CMR methods have
een established for assessment of global and regional
ardiac function, myocardial perfusion, myocardial viability,
See page 2182
nd proximal coronary anatomy (1–11). Individually, these
ethods have shown promise as alternatives to the estab-
ished tools for the noninvasive detection of obstructive
oronary stenosis and myocardial infarction (3,4,6,9,10). A
nique advantage to CMR imaging is that several of its
ethods can be combined in a single scanning session (12).
he diagnostic accuracy provided by such a comprehensive
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nfirmary at Leeds, Leeds, United Kingdom; ‡Clinical Trials Research Unit,
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niversity of Leeds, Leeds, United Kingdom. Dr. Plein was supported by a British
eart Foundation Fellowship grant.a
Manuscript received March 22, 2004; revised manuscript received July 19, 2004,
ccepted August 10, 2004.ulticomponent CMR study has not previously been eval-
ated in a wider patient population. Importantly, it is also
ot known if the combined analysis of several CMR
ethods increases the diagnostic performance over analysis
f individual methods.
Patients who could benefit particularly from noninvasive
ssessment with CMR are those presenting with non–ST-
egment elevation acute coronary syndromes (NSTE-ACS).
ne of the most important clinical decisions in these
atients is to determine which patients require early revas-
ularization because of the presence of flow-limiting coro-
ary stenosis. Current guidelines recommend that patients
t high or intermediate risk of future vascular events should
ndergo early invasive testing (13). Several risk-
tratification tools such as the Thrombolysis In Myocardial
nfarction (TIMI) risk score have been proposed to guide
his decision process (14). However, in clinical trials, be-
ween a quarter and a half of patients presenting with
STE-ACS had no obstructive CAD that required revas-
ularization (15–19).
Kwong et al. (20) have recently shown that CMR is more
ccurate than the TIMI score to predict the diagnosis of
cute coronary syndromes (ACS) in a low-risk group of
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CMR Imaging of NSTE-ACS December 7, 2004:2173–81atients presenting with chest pain in the emergency room.
owever, the important clinical question as to whether
MR can predict the need for revascularization in patients
ith known or suspected ACS has not yet been addressed.
urthermore, the applicability of CMR to patients at the
igh end of the risk spectrum, who are most likely to require
arly invasive investigation, has not yet been studied.
In this study we hypothesized that CMR imaging would
e an accurate tool to detect the presence of flow-limiting
oronary stenosis in patients with a clinical diagnosis of
STE-ACS. We further speculated that the combined
nalysis of several CMR methods would have an
ncremental benefit on the diagnostic accuracy of CMR
ompared with the assessment of any single component.
ETHODS
ubjects. A total of 72 patients (56 men and 16 women,
ean age 57 years, range 37 to 75 years) with a clinical
iagnosis of NSTE-ACS who were listed for coronary
ngiography during their index admission were recruited for
he study. The diagnosis of NSTE-ACS was based on the
resence of one or more of the following: suspected cardiac
hest pain, a rise in the serum troponin-I levels (by a single
easurement 12 h after presentation), and/or ischemic
hanges on the electrocardiogram (ST-segment depression,
-wave abnormalities, or transient ST-segment elevation).
he decision to list patients for coronary angiography was
ade on clinical grounds by their treating physicians and
as not determined by formal risk assessment; TIMI risk
cores were calculated for each patient after recruitment to
he study.
Patients gave informed written consent in accordance
ith a protocol approved by the institutional ethics com-
ittee. Exclusion criteria for the study were overt clinical
eart failure and contraindications to CMR imaging or
denosine infusion. Nine patients had a documented history
f myocardial infarction, and five had previous percutaneous
oronary intervention. Further patient characteristics are
isted in Table 1.
MR protocol. Patients underwent CMR imaging within
2 h of admission and 24 h before coronary angiography.
ny substances containing caffeine were withheld for 12 h
efore the study. Patients were placed supine in a 1.5-T
canner (Philips Medical Systems, Best, the Netherlands)
Abbreviations and Acronyms
ACS  acute coronary syndrome
CAD  coronary artery disease
CMR  cardiac magnetic resonance
LAD  left anterior descending artery
LCX  left circumflex coronary artery
NSTE-ACS  non–ST-segment elevation acute coronary
syndrome
RCA  right coronary arteryquipped with “Master” gradients (30 mT/m, 150 mT/s clew rate) and a five-element cardiac phased-array receiver
oil. Heart rate, blood pressure, and the electrocardiogram
ere monitored continuously. The CMR protocol is shown
chematically in Figure 1. Except for coronary imaging, all
cquisitions were performed during short breath-hold peri-
ds. The study commenced with the acquisition of survey
mages to determine the true left ventricular short axis and
reference image of the receiver-coil sensitivity. Resting
yocardial perfusion was then assessed. For this, a bolus of
.05 mmol/kg dimeglumine gadopentetate followed by a
0-ml saline flush was administered at 6 ml/s into an
ntecubital vein by a power injector (Spectris, Medrad,
ittsburgh, Pennsylvania). A dynamic sequence of images
as acquired over 40 s with a T1-weighted saturation
ecovery segmented k-space gradient echo pulse sequence
ombined with sensitivity encoding (echo time, 1.6 ms;
epetition time, 3.3 ms; flip angle 15°, four parallel short-
xis slices, spatial resolution 2.5 to 3.0 3.0 to 4.0 8 mm)
21). For measurements of ventricular function, cine imag-
ng covering the whole heart in 10 to 12 parallel short-axis
lices was then performed using a steady-state free preces-
ion pulse sequence (echo time, 1.4 ms; repetition time, 2.8
s; flip angle 55°, spatial resolution 2  2  7 mm, 18
hases per cardiac cycle) (22). This was followed by a
able 1. Baseline Demographic Characteristics, Cardiac Risk
actors, Drug Therapy, and Presenting Characteristics of
atients Included in the Analysis (n  68)
ender, n (%)
Male 54 (79%)
Female 14 (21%)
ge (yrs) 57 (11)
isk factors, n (%)
Diabetes mellitus 6 (9%)
Hypertension 21 (31%)
Hypercholesterolemia 42 (62%)
Previous MI 9 (13%)
Family history of CAD 35 (51%)
Current smoker 31 (46%)
Previous coronary angioplasty 5 (7%)
Stroke 1 (1%)
edications at time of randomization, n (%)
Aspirin 64 (94%)
Beta-blocker 57 (84%)
ACE inhibitor 21 (31%)
Statin 51 (75%)
resenting characteristics
Systolic blood pressure (mm Hg) 121 (17)
Troponin-I levels 0.1 mg/ml, n (%) 36 (53%)
Mean maximal troponin level (mg/ml) 2.9 (10)
Creatine kinase level 400 IU, n (%) 27 (40%)
Mean maximal creatine kinase level (IU) 266.8 (377.2)
ST-segment depression (0.1 mV), n (%) 19 (28%)
Transient ST-segment elevation (0.1 mV), n (%) 8 (12%)
T-wave inversion or ischemic T changes 22 (32%)
Bundle branch block (old) 3 (4%)
Left ventricular ejection fraction (%)† 57.7 (8.6)
Values are mean  SD; †left ventricular ejection fraction calculated from cardiac
agnetic resonance data using standard methods (22).
ACE  angiotensin-converting enzyme; CAD  coronary artery disease; MI 
yocardial infarction.oronary localizer scan and the first of two targeted, high-
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December 7, 2004:2173–81 CMR Imaging of NSTE-ACSesolution coronary CMR acquisitions. The first coronary
mage plane was aligned in the path of the right coronary
rtery (RCA) and also covering, where possible, that of the
eft circumflex artery (LCX). Acquisition used a T2-
repared three-dimensional free-breathing technique with
rospective respiratory gating based on navigator echoes
cquired through the right hemidiaphragm (echo time, 2.1
s; repetition time, 7 ms; flip angle 25°, 16 overlapping
lices, reconstructed spatial resolution 0.78  1.04  1.5
m) (23). Stress perfusion was then assessed during a
-min intravenous administration of adenosine (140 g/kg/
in) and the data obtained with identical parameters as for
he resting perfusion acquisition. This was followed imme-
iately by injection of a further 0.1 mmol/kg of contrast in
reparation of viability imaging. Then the second coronary
MR data set was obtained aligned to cover the left main
nd proximal and mid-left anterior descending (LAD) and
CX arteries. Finally, late contrast-enhanced imaging for
he assessment of viability was carried out using an inversion
ecovery segmented k-space gradient echo pulse sequence
ith a nonselective 180° prepulse (echo time, 3.8 ms;
epetition time, 7.5 ms; flip angle 15°, inversion time
djusted individually to suppress signal from normal myo-
ardium, 8 to 10 short-axis slices, spatial resolution 1.8 
.8  10 mm).
MR analysis— comprehensive analysis. Two separate
nalyses of CMR data were carried out on a commercially
vailable workstation (Philips Easyvision Version 4.0,
hilips, Best, the Netherlands). In a first analysis, which
imed to reflect the likely clinical use of a comprehensive
MR protocol, two observers (S.P., J.P.G.) who were
linded to clinical data were given unrestricted access to all
MR images of each patient and analyzed these in combi-
ation (this analysis will be referred to as the “comprehen-
ive analysis”). The presence of significant CAD (i.e.,
ow-limiting or 70% luminal narrowing) was reported for
he three coronary artery territories as per the American
eart Association definition (24) and in individual patients.
ardiac magnetic resonance was interpreted as abnormal if
igure 1. Cardiac magnetic resonance (CMR) imaging protocol. Times a
ubsequent CMR images. The protocol commences with localizer images
esting myocardial perfusion acquisition is then performed using 0.05 mmo
s acquired, followed by a high-resolution angiogram aligned along the cour
s then performed, immediately followed by injection of a further 0.1 mmo
he left coronary vessels is then acquired, followed by viability images usinne or more components of the study showed an abnormal- lty in a coronary artery territory, but, in this analysis, the
bservers were allowed to discard components with poor
mage quality or significant artifacts and base their evalua-
ion on the remaining data.
MR analysis—individual components. In order to as-
ess the performance of the individual CMR components, a
eparate second analysis session was carried out in which the
our CMR components (function, perfusion, viability, and
oronaries) were analyzed individually. At least two weeks
eparated the comprehensive and each of the individual
nalyses of the same patient. For this analysis, the observers
ad access to data from only one CMR component at a
ime. For each component, abnormalities in the three
oronary artery territories as per American Heart Associa-
ion definition (24) and in individual patients were reported.
rom the cine images, left ventricular function was graded
s normal or impaired. Rest and stress perfusion data were
nalyzed as a single component and were reviewed in the
ovie-mode and by scrolling through the series of dynamic
mages. Perfusion was considered abnormal if the first pass
f the contrast was delayed or the peak signal intensity was
ower than in other parts of the myocardium. Both fixed
present at rest and stress) or inducible (present only at
tress) perfusion defects were reported as abnormal. Late
ontrast-enhanced images were regarded as abnormal if any
yperenhancing myocardium was present. Coronary CMR
mages were analyzed by scrolling through the slices of the
hree-dimensional data sets, and stenoses that appeared to
e 70% were reported as abnormal. For presentation
urposes, coronary CMR images were reformatted after the
nalysis using SoapBubble software (Philips Medical Sys-
ems, Best, the Netherlands) (25).
-ray coronary angiography. X-ray coronary angiography
as performed within 24 h after the CMR study using a
tandard technique (26). Two experienced cardiologists (the
reating physician and M.U.S.) carried out qualitative anal-
sis of the coronary angiograms independently and without
nowledge of the CMR data. They reported the presence of
ignificant CAD if one or more coronary stenosis of 70%
roximations; gaps between imaging blocks indicate time for planning of
reference scan that is required to utilize sensitivity encoding (SENSE). A
body weight of dimeglumine gadopentetate. Next, a coronary scout image
he right coronary artery (RCA). An adenosine-stress perfusion acquisition
f contrast in preparation for viability imaging. An angiogram targeted on
te contrast-enhanced technique.re app
and a
l/kg
se of t
l/kg ouminal narrowing was seen in a main coronary vessel or
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CMR Imaging of NSTE-ACS December 7, 2004:2173–81ajor side branch of 2 mm diameter. In case of disagree-
ent between the two observers, a consensus decision was
ade.
tatistical analysis. The sensitivity, specificity, overall di-
gnostic accuracy, negative and positive predictive values,
ogether with their corresponding 95% confidence intervals
or the ability of visual CMR analysis to detect the presence
f significant CAD were calculated using standard methods.
his analysis was carried out for patients as a whole and for
ndividual coronary territories. The sensitivity, specificity,
nd overall diagnostic accuracy of the comprehensive anal-
sis in comparison with each CMR component were com-
ared using McNemar’s chi-square test. These analyses
ere repeated for the comparisons of a TIMI score3 with
he combined analysis. All statistical tests were two-sided
nd performed at the 5% significance level. Analysis was
onducted using SAS version 8.2 (SPSS Inc., Chicago,
llinois).
Exploratory analyses were then conducted on combina-
ions of several of the CMR components. For this, the
esults of individual CMR components were combined and
erived as abnormal if one or more components were
bnormal and normal if all components were normal. All
ossible combinations of two CMR components were
nalyzed as well as the three-way combinations of perfu-
ion/wall motion/late contrast enhancement and coronaries/
all motion/late contrast enhancement. The resulting com-
ined scores were compared with the comprehensive
nalysis using the methods described in the preceding text.
Finally, logistic regression modeling was used to assess
he ability of each individual CMR component to predict
he presence of significant CAD. A multivariate logistic
egression model was constructed using a forward selection
rocedure, with a p value 0.05 for model entry, to assess
he incremental predictive value of including each CMR
omponent in the model.
ESULTS
MR imaging. Results of 68 patients are reported. Three
MR studies were not completed; two patients were claus-
rophobic, and one patient was intolerant to adenosine
transient breathlessness and chest tightness). One patient
as found to have asymmetric left ventricular hypertrophy
n CMR and was, therefore, excluded from the analysis.
No adverse events occurred, and all 68 patients tolerated
he CMR study well, including the pharmacologic stress
omponent. The mean CMR imaging time was 62.5  7.7
in.
Example images of one study patient, which illustrate the
omprehensive range of information provided by CMR, are
hown in Figure 2. Cardiac magnetic resonance suggested a
arge amount of viable myocardium at risk from a significant
AD stenosis, which was confirmed by X-ray angiography.
urther examples of abnormalities detected by CMR are
hown in Figures 3 to 5. igure 2. Selected cardiac magnetic resonance (CMR) images from one
tudy patient. Cardiac magnetic resonance findings in a 49-year-old
ale patient (presented with anterolateral ST-segment depression,
roponin 0.2 mg/l). Only one short-axis image of selected CMR
cquisitions is shown. Cine images demonstrate anteroseptal hypoki-
esia, diastolic frame at midventricular level in (a), systolic frame in (b),
hite arrows. Stress perfusion imaging (c) shows an anteroseptal
erfusion defect. Late contrast-enhanced images (d) show no hyperen-
ancement, indicating that the entire myocardium is viable. Coronary
MR shows a lesion in the mid-left anterior descending coronary artery
LAD) (e, dotted arrow), with normal left circumflex coronary artery
LCX) and right coronary artery (RCA) (f). The combined CMR
nalysis thus suggested significant coronary artery disease with a
tenosis of the LAD and a large area of viable myocardium at ischemic
isk. X-ray angiography, (g and h), confirmed a proximal high-grade
esion in the LAD (dotted arrow), with a normal LCX and RCA. LVleft ventricle; RV  right ventricle.
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December 7, 2004:2173–81 CMR Imaging of NSTE-ACS-ray angiography. Of the 68 patients who were analyzed,
6 had significant CAD on X-ray angiography. A total of
0 patients had single-vessel disease, 19 two-vessel disease,
nd 7 patients had three-vessel disease; 39 lesions were
ocated in the left main/LAD, 22 in the LCX, and 28 in the
CA. A total of 36 patients were treated by percutaneous
oronary angioplasty to 44 vessels, and 10 patients under-
ent coronary artery bypass grafting. In 10 patients with
ignificant CAD, immediate revascularization was not car-
ied out. The reasons for not proceeding to immediate
evascularization were: poor surgical targets for coronary
rtery bypass grafting (n  3), presumed chronic coronary
cclusions (n  3), significant comorbidity resulting in
njustifiable risk for coronary artery bypass grafting (n 2),
nd patients refusing coronary artery bypass grafting
n  2).
etection of significant CAD— comprehensive CMR
nalysis. The sensitivity, specificity, positive and negative
redictive values, and overall accuracy for CMR analysis are
rovided in Table 2. Sensitivity and specificity are also
resented in Figure 6. The comprehensive analysis of all
MR data correctly identified the presence of significant
AD in 54 patients (sensitivity 96%). A total of 10 of the
2 patients without significant CAD on X-ray angiography
igure 3. Cardiac magnetic resonance imaging examples from three study
ne midventricular slice of the stress images. (a) Inducible anteroseptal sub
cclusion of the proximal left anterior descending coronary artery (LAD). (
urther small transmural septal perfusion defect (black arrow). X-ray an
ircumflex coronary artery. (c) Inferior transmural perfusion defect (white ar
rtery.
igure 4. Cardiac magnetic resonance imaging examples from three study
mall area of hyperenhancement at the inferolateral junction (arrow) in
lectrocardiogram (ECG) (serum troponin level 7.5 mg/l). (b) Subendocard
apillary muscle, in a patient who had no significant electrocardiogr
yperenhancement with a central hypoenhancing zone indicating no-r
on–ST-segment elevation myocardial infarction, and a standard 12-lead ECG
reatinine kinase was 1,910 IU and troponin 12.3 mg/l.ere identified as normal (specificity 83%). The overall
iagnostic accuracy of the analysis was 94%, the negative
redictive value 83%, and the positive predictive value 96%.
For individual coronary territories, sensitivity and speci-
city were 84%/77% for the left main/LAD, 65%/90% for
he LCX, and 88%/62% for the RCA.
etection of significant CAD—individual CMR
omponents. Of the individual CMR components, perfu-
ion yielded the highest sensitivity, specificity, and overall
ccuracy. Wall motion and late contrast enhancement
ielded low sensitivities but high specificities (Table 2 and
ig. 6).
Compared with the comprehensive analysis, the sensitiv-
ty of perfusion showed no statistically significant difference
p  0.13). The sensitivity of coronaries (sensitivity 84%),
all motion (sensitivity 68%), and late contrast enhance-
ent (sensitivity 57%) were significantly lower than the
ensitivity of the comprehensive analysis (p  0.039, p 
.001 and p  0.001, respectively). There were no statistically
ignificant differences between the specificities of the compre-
ensive analysis and each individual CMR component.
The overall diagnostic accuracy of wall motion (accuracy
9%) and late contrast enhancement (accuracy 62%) were
ignificantly lower than the overall diagnostic accuracy of
ts with a variety of myocardial perfusion deficits. All examples show only
ardial perfusion defect (white arrow). X-ray angiography showed subtotal
ducible lateral perfusion defect in a thinned lateral wall (white arrow) and
phy showed significant stenosis of the mid-LAD and an occluded left
X-ray angiography showed a significant stenosis in the mid-right coronary
ts with a variety of abnormalities on late contrast-enhanced images. (a) A
tient with transient inferior ST-segment depression on the presenting
perenhancement of the inferior wall, which appears to involve the posterior
changes (serum troponin level 0.7 mg/l). (c) Lateral full thickness
in the infarct core (arrow). Clinically, this patient presented with apatien
endoc
b) In
giogra
row).patien
a pa
ial hy
aphic
eflowshowed only minimal ST-segment depression in the lateral leads. Peak
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CMR Imaging of NSTE-ACS December 7, 2004:2173–81he comprehensive analysis (p  0.001 for both). There was
o statistically significant difference between the overall
ccuracy of the comprehensive analysis and perfusion (ac-
uracy 87%, p  0.18) or coronaries (accuracy 82%, p 
.11).
etection of significant CAD— combinations of indi-
idual CMR components. Results of the exploratory anal-
ses of combinations of individual CMR components are
iven in Table 3. Of the two-component combinations,
nalysis of perfusion plus coronary data showed the highest
ensitivity (98%), which was significantly higher than the
ensitivity of either perfusion (sensitivity 88%, p  0.03) or
oronaries alone (sensitivity 84%, p  0.008). The combi-
ation of wall motion and late enhancement had the lowest
ensitivity of the two-component combinations (77%) and
as significantly less sensitive than the comprehensive
nalysis (96%, p  0.001). There were no statistically
ignificant differences between the sensitivities of either of
he other two component combinations and the compre-
ensive analysis. All combinations had similar specificities
igure 5. Cardiac magnetic resonance (CMR) imaging examples from thre
ith corresponding X-ray angiograms. The CMR angiograms in the top ro
rrows) of the mid-left anterior descending artery (LAD). (b and e) Steno
dotted arrows) of the mid-right coronary artery (RCA).
able 2. Comprehensive CMR Analysis and Analysis of Individu
ignificant CAD*
Sensitivity
(%)
Specifi
(%)
omprehensive analysis 96 (92–100) 83 (62–
ndividual component analysis
Perfusion 88 (79–96) 83 (62–
Coronaries 84 (74–94) 75 (51–
Wall motion 68 (56–80) 75 (51–
Late contrast enhancement 57 (44–70) 83 (62–Results are given as percentages with 95% confidence intervals.
CAD  coronary artery disease; CMR  cardiac magnetic resonance; NPV  negativith no statistically significant differences compared with
he comprehensive analysis.
There were no statistically significant differences between
ither of the three-way combinations (perfusion/wall mo-
ion/late enhancement and coronaries/wall motion/late en-
ancement) and the comprehensive analysis in terms of
ensitivity, specificity, or overall accuracy.
ogistic regression analysis for the prediction of
ignificant CAD. From the logistic regression analysis,
erfusion was the most significant individual predictor (p 
.0001) of the presence of significant CAD. The inclusion
f coronaries significantly increased the predictive power of
he logistic regression model containing perfusion alone
chi-square [8.29], p  0.004). The inclusion of wall
otion or late enhancement did not add any incremental
redictive power to the model.
IMI score >3. A total of 38 patients had a low TIMI
isk score (0 to 2), 27 had an intermediate risk score (3 to 4),
nd 3 patients had a high TIMI score (5 to 7). In
omparison with the comprehensive analysis, a TIMI
y patients showing abnormalities of coronary CMR angiograms compared
rresponding X-ray angiograms in bottom row. (a and d) Stenosis (dotted
otted arrows) in the proximal circumflex artery (LCX). (c and f) Stenosis
MR Components for the Detection of the Presence of
PPV
(%)
NPV
(%)
Overall
Accuracy (%)
96 (91–100) 83 (62–100) 94 (88–100)
96 (91–100) 59 (35–82) 87 (79–95)
94 (87–100) 50 (27–73) 82 (73–92)
93 (85–100) 50 (27–73) 69 (58–80)
94 (86–100) 42 (25–58) 62 (50–73)e stud
w, coal C
city
100)
100)
100)
100)
100)e predictive value; PPV  positive predictive value.
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December 7, 2004:2173–81 CMR Imaging of NSTE-ACScore 3 had a significantly lower sensitivity (sensitivity:
IMI  50%, CMR  96%, p  0.001) and overall
ccuracy (overall accuracy: TIMI  56%, CMR  94%,
 0.001) to detect the presence of significant CAD. The
pecificities were the same (83%), but a TIMI score 3 had
very low negative predictive value (26%) indicating a high
umber of false negatives if a TIMI score 3 was used to
dentify patients with significant CAD.
ISCUSSION
ur results show that: 1) CMR imaging is feasible and safe
n patients with NSTE-ACS; 2) CMR can accurately
dentify patients within this high-risk population who have
ignificant coronary stenosis; 3) combining several CMR
omponents increases the diagnostic yield of the study; and
) CMR is more accurate than the TIMI risk score in this
ontext.
This is the first report of CMR imaging with pharma-
ologic stress in patients presenting with ACS. We encoun-
ered no complications in our study, and 68 of 72 patients
ompleted the whole examination. Failure rates due to
laustrophobia and adenosine intolerance were comparable
igure 6. Prediction of significant coronary artery disease by comprehen-
ive analysis of all cardiac magnetic resonance data by separate analysis of
he four cardiac magnetic resonance components, and by a Thrombolysis
n Myocardial Infarction (TIMI) risk score of 3. Coros  coronary
agnetic resonance angiography; LeMRI  late contrast-enhanced mag-
etic resonance imaging; WM  wall motion analysis. Solid bars 
ensitivity; open bars  specificity.
Table 3. Combinations of Separate Analyses o
Presence of CAD Requiring Revascularization
Sensi
Combinations of two CMR components
Perfusion/coronaries 98
Perfusion/wall motion 93
Perfusion/late contrast enhancement 95
Coronaries/wall motion 93
Coronaries/late contrast enhancement 91
Wall motion/late contrast enhancement 77†
Combinations of three CMR components
Perfusion/wall motion/late contrast
enhancement
95
Coronaries/wall motion/late contrast
enhancement
95
*Results are given as percentages with 95% confidence inter
The combinations of two or three individual components wer
normal if all components were normal.
CAD  coronary artery disease; CMR  cardiac magnetic reso previous reports in other patient groups (10,11). Our
esults, therefore, suggest that CMR imaging with adeno-
ine stress can be safely applied to patients with NSTE-
CS.
Our results further suggest that CMR can be used to
oninvasively detect the presence of significant CAD and,
hus, determine the need for invasive assessment in patients
resenting with NSTE-ACS. Although X-ray angiography
ould still be needed for those patients who undergo
evascularization, CMR could provide a safe screening tool
o select appropriate patients for invasive testing. At the
evel of accuracy reported here for the comprehensive CMR
nalysis, approximately one-third of X-ray angiograms
ould potentially be avoided (15–19). Importantly, the wide
ange of information provided by a comprehensive CMR
tudy would also then complement the X-ray angiogram
nd guide appropriate clinical management, particularly of
atients who require revascularization. Current guidelines
mphasize that the decision to proceed to coronary revas-
ularization in patients with CAD should not be based on
he coronary anatomy alone, as is often the case in clinical
outine, but should also consider ventricular function, the
uantity of viable myocardium, and myocardium at ischemic
isk (13). Only then can informed decisions regarding the
ppropriateness and benefits versus the risks of revascular-
zation be taken. In current practice, this information is
ften not sought, because several different diagnostic mo-
alities would have to be used. As we have shown and as
llustrated in our figures, CMR could provide all the
elevant data from a single noninvasive investigation.
The results of individual CMR components in our study
ere comparable to previous reports in other patient groups
3,4,9,10,12). In our population, perfusion imaging yielded
he highest sensitivity and overall accuracy of any individual
omponent and was the best individual predictor of the need
or revascularization, followed by coronary CMR angiogra-
hy. Interestingly, our visual perfusion analysis method
ielded accuracy similar to previously reported semiquanti-
R Components in the Detection of the
onfirmed by X-Ray Angiography)*
(%) Specificity (%) Overall Accuracy (%)
00) 67 (40–94) 93 (86–99)
00) 75 (51–100) 90 (82–97)
00) 75 (51–100) 91 (85–98)
00) 67 (40–93) 88 (81–96)
9) 67 (40–93) 87 (79–95)
8) 75† (51–100) 77† (66–87)
00) 75 (51–100) 91 (85–98)
00) 67 (40–94) 90 (82–97)
statistically significant difference to comprehensive analysis.
ed as abnormal if one or more component was abnormal andf CM
(as C
tivity
(95–1
(87–1
(89–1
(87–1
(84–9
(66–8
(89–1
(89–1
vals; †
e derivonance.
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CMR Imaging of NSTE-ACS December 7, 2004:2173–81ative methods (3,4). We speculate that this is, in part, due
o our perfusion protocol, which may have been more
ptimized for visual analysis than in previous studies that
eported a poorer performance of visual analysis compared
ith semiquantitative testing.
Our results have shown for the first time that the
ombined analysis of several CMR methods increases its
iagnostic yield compared with analysis of individual meth-
ds. The separate analysis of individual CMR components
an be limited by technical and practical problems such as
maging artifacts due to registration errors or poor patient
reath-holding. Also, some measures such as viability im-
ging have a limited sensitivity by their very nature, as they
nly detect areas of completed infarction. In this study, and
n our specific patient population, combining perfusion and
oronary analyses significantly increased the sensitivity of
MR analysis and increased the predictive power in the
ogistic regression model. The best overall accuracy was
chieved by the comprehensive analysis in which the ob-
ervers had unrestricted access to all CMR data. Impor-
antly, this did not come at the expense of a lower specificity
ompared with the analysis of single components. The main
eason for this increased accuracy is that myocardial func-
ion, perfusion, viability, and coronary anatomy each assess
different manifestation of CAD and together provide a
ide range of complementary information. Having access to
ata from other CMR methods is especially useful when
ne component shows a borderline result or is affected by
mage artifacts. This allows the observers to come to a more
onfident conclusion and, as we have shown, reduces false
egative reports without increasing the false positives.
When we combined the results of individual CMR compo-
ents in further exploratory analyses, the three-way combina-
ions of perfusion/wall motion/late contrast enhancement and
oronaries/wall motion/late contrast enhancement yielded ac-
uracies comparable to the comprehensive analysis of all CMR
ata. In clinical practice, the former of these combinations
ould be particularly attractive because it avoids the need for
ime-consuming coronary CMR imaging and still provides the
elevant clinical data of myocardial ischemia and viability. If
onfirmed in larger studies, this combination may offer an
cceptable compromise between the time constraints encoun-
ered in clinical practice and the advantages of a more com-
rehensive CMR study.
We have studied a patient population at the high end of
he risk spectrum, in whom a diagnosis of NSTE-ACS and
he decision to proceed to X-ray angiography had already
een taken by the treating physician. Although it is a
imitation of our work that the number of patients without
ignificant CAD was low given the high-risk group we have
tudied, our population complements a recent report by
wong et al. (20) that demonstrated the ability of CMR to
dentify ACS in patients at the opposite lower end of the
isk spectrum. We suggest that patients with a high risk of
uture clinical events and a high prevalence of CAD, studied
n the present report, are most likely to require and benefit irom invasive management and that it was, therefore, highly
elevant to demonstrate that CMR can be used in patients
ith established or high-risk ACS. Although the role of
MR in the diagnostic pathway for CAD has yet to be
stablished, the study by Kwong et al. (20) and our results
aken together show that CMR can be applied across a wide
ange of disease prevalence.
In our study as well as in the report by Kwong et al. (20),
MR was more sensitive and accurate than the TIMI risk
core to detect ACS and the need for revascularization,
espectively. The TIMI risk score and other similar tools are
esigned to determine the risk of future cardiovascular
vents rather than to detect ACS or the need for revascu-
arization, but are often used in clinical practice to select
atients for early X-ray angiography in accordance with
urrent guidelines (6). Cardiac magnetic resonance appears
o be superior to the TIMI risk score to identify patients
ho will benefit from early invasive management. We
uggest that the most important reason for the higher
ensitivity of CMR compared with the TIMI risk score is
hat, rather than relying on indirect measures such as the
lectrocardiogram and biochemical markers, CMR allows a
irect visual assessment of the pathologic processes that
ccur in NSTE-ACS and, in particular, detects myocardial
schemia. Another reason why the TIMI risk score may be
relatively weak predictor of the presence of significant
AD is that it includes a number of nonspecific and
ommon risk factors. The current study could not formally
ompare the ability of CMR and the TIMI risk score to
redict future clinical events, because only six cardiovascular
nd points occurred during follow-up. However, all end
oints occurred in patients with abnormal CMR studies,
hich suggests that CMR may offer prognostically relevant
nformation. This will need to be confirmed in larger studies
nd compared with conventional methods of risk
tratification.
We used the presence of significant CAD in patients
ather than in individual vascular territories as the main end
oint of this study. The main reason for this is that, in the
linical context of suspected NSTE-ACS, we regarded the
etection of CAD in a patient as the most important
otential role for a noninvasive screening test to identify
hose patients who should be referred for invasive testing.
he localization of disease to an individual coronary artery,
hile also possible as we have shown, is less important in
his scenario. Another reason for our choice of this end
oint was that we wanted to compare CMR with the TIMI
isk score, which, of course, does also not allow localization
f disease.
In conclusion, this study has shown that CMR imaging is
afe and accurate in patients presenting with NSTE-ACS.
t can be used for the triage of patients to early invasive
anagement or to provide important additional informa-
ion in combination with X-ray angiography for a fully
nformed treatment of patients with NSTE-ACS.
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